Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.
Description
Merlin's CardioMotionTM echo analysis and reporting software, distributed by CDN in Australia, revolutionizes support for swiftly identifying cardiac problems. Designed for use in emergency medicine, CCU/ICU settings, oncology departments, medical center clinicians, ultrasound facilities, cardiology units, and even in regional or remote locations that rely on point-of-care devices, it also proves advantageous for cardiac monitoring during clinical trials. What sets Merlin CardioMotionTM apart is its ability to process slow frame rate echo clips accurately without needing an ECG trace for detection, making it compatible with lower-specification ultrasound machines. Employing groundbreaking image processing technology, it is built upon a foundation of proprietary algorithms that facilitate the automatic identification of the ventricular wall and its borders. This innovative approach allows for a swift and precise quantitative evaluation of the heart's dynamic functioning, ultimately enhancing patient care. With its capabilities, healthcare providers can make informed decisions and improve outcomes in cardiac health management.
API Access
Has API
No
API Access
Has API
No
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Cleerly
Country
United States
Website
cleerlyhealth.com
Vendor Details
Company Name
Central Data Networks
Country
Australia
Website
www.cdnpacs.com/cardiology/cardiac-analysis/cardiomotion/
Product Features
Product Features
Medical Imaging
Automated Routing
No
Comparison View
No
Compliance Management
No
Data Import / Export
No
Diagnostic Reporting
No
Image Analytics
No
Treatment Planning
No
Workflow Management
No